“Lilly Invests $2.5 Billion in First German Facility to Meet Soaring Demand for Weight-Loss Drugs”
In response to the surging demand for weight-loss drugs, pharmaceutical giant Eli Lilly (LLY) has unveiled plans to invest a substantial $2.5 billion in constructing its inaugural manufacturing facility in Germany. The high-tech plant, situated in Alzey, Germany, is anticipated to fortify Lilly’s injectable product and device manufacturing network. This strategic move comes as the … Read more